4/A

OWNERSHIP DOCUMENT

Company: Zenas BioPharma, Inc.
Filed: April 28, 2025
Period of Report: February 7, 2025
Accession Number: 0001104659-25-039771

View Document ↗ View on SEC.gov ↗